Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys.
Kushala W M AbeysekeraAnkur SrivastavaIan RoweHelen JarvisStephen D RyderAndrew D YeomanJohn F DillonWilliam M RosenbergPublished in: Frontline gastroenterology (2023)
Between 2014 and 2021, the role of NITs in fibrosis assessment has risen substantially, as has the proportion of clinicians using NITs in clinical pathways to assess risk of liver disease. Poor access to NITs remains the predominant barrier.